Pneumotox » Drug » Erythromycin » X.h - Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Erythromycin

X.h Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Extremely low evidence in one remote article (Dietz A, Hubner C, Andrassy K. Severe adverse effects (Churg-Strauss syndrome) after the intake of macrolides. Laryngo Rhino Otol 1998; 77: 111-114)

Last update : 10/08/2012

Diagnosing DIRD

Drug and radiation history

Drug singularity - Correct identification of the drug

Consistent timing of exposure v. onset of symptoms

Clinical, imaging, BAL, pathological pattern consistent with the specific drug

Careful exlusion of another cause

Remission of symptoms with removal of drug

Recurrence with rechallenge (rarely advisable)

Causality assessment

More detailed checklist

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

Erythromycin

X.h Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Publications